TY  - JOUR
PY  - 2023//
TI  - Epidemiology of mental health comorbidity in patients with psoriasis: an analysis of trends from 1986 to 2019
JO  - Psychiatry research
A1  - Liu, Liu
A1  - Lin, Nai-Xuan
A1  - Yu, Yuan-Ting
A1  - Wang, Si-Han
A1  - Wang, Jiao
A1  - Cai, Xiao-Ce
A1  - Wang, Chun-Xiao
A1  - Zhang, Miao
A1  - Li, Xin
A1  - Li, Bin
SP  - e115078
EP  - e115078
VL  - 321
IS  - 
N2  - BACKGROUND: The prevalence of mental disorders such as depression, anxiety, and suicide has increased in patients with psoriasis, although no study has systematically analyzed the epidemiology worldwide. <br><br>OBJECTIVE: To explore the prevalence and incidence of psoriasis with comorbid mental disorders (i.e., depression, anxiety, and suicide). <br><br>METHODS: Five databases from establishment through May 2022 were searched. Stata SE 15.1 was used for the data analysis. Subgroup, meta-regression, and sensitivity analyses were used to evaluate the heterogeneity of pooled studies. <br><br>RESULTS: We evaluated 56 studies in our research. The prevalence of depression, anxiety, and suicide in adults with psoriasis was 20%, 21%, and 0.77%. Patients with psoriasis in North America had a higher prevalence of depression and suicide, whereas those in South America had a higher prevalence of anxiety. The incidence of depression, anxiety, and suicide was 42.1, 24.7, and 2.6 per 1000 person-years in adults with psoriasis, respectively.     LIMITATIONS: All of the included studies were published in Chinese and English, causing a degree of selection bias. <br><br>CONCLUSION: These findings demonstrate the incidence and prevalence of comorbid mental disorders in patients with psoriasis, which may raise awareness among physicians and patients regarding the mental problems associated with psoriasis.<p />  <p>Language: en</p>
LA  - en
SN  - 0165-1781
UR  - http://dx.doi.org/10.1016/j.psychres.2023.115078
ID  - ref1
ER  -